October 19, 2018 | by Healthcare Weekly Staff

Abbott’s MitraClip for Heart Failure Patients

The Mitraclip, developed by Chicago-based Abbott Laboratories, can greatly reduce death rates in patients with severe heart failure, according to a new study published in the New England Journal of Medicine.

The tiny device inserted into the heart via a catheter greatly boosts survival rates among patients with severe heart failure. Cardiologists call the procedure “ a game changer.” The Food and Drug Administration (FDA) already approved the clip for patients too frail for surgery, but whose hearts are healthy except for a diseased mitral valve.

Healthcare Weekly Staff
Healthcare Weekly Staff

The Healthcare Weekly staff brings you the latest in healthcare innovation, technology, news and more.

Leave a comment

Contact us

Get in touch to learn how we can help

Name

Work Email

Message

Are you a CEO? Apply to join

Join an exclusive community of healthcare leaders reshaping the industry.

Learn from industry leaders

Connect with like-minded CEOs

Build your personal brand

Explore the benefits

Contact us

Get in touch to learn how we can help

Name

Work Email

Message

Thank you for contacting Healthcare Weekly.

We will get in touch with you shortly.